Kiwa is an independent global company in Testing, Inspection and Certification. Kiwa’s core businesses are supported and strengthened by training, consultancy, and data services. With SHV, Kiwa found a new shareholder with a well-known culture that will invest in accelerating growth of the company, while SHV further diversifies its portfolio with the acquisition.
Clairfield International was first introduced to Kiwa when it advised Gastec in the sale to Kiwa in 2005, followed by its onboarding as the company’s trusted adviser in Kiwa’s carve-out from 13 Dutch Drinking Water Companies in the same year. In the years that followed, Clairfield advised Kiwa in separating its commercial TIC activities from research activities KWR, the sale of Kiwa to PE company ABN AMRO Participations and implementing the consecutive refinancing and buy-and-build strategy. After advising Kiwa in the sale to NPM Capital in 2011, it assisted the company in further optimizing its activity portfolio, among others with the divestment of the Shield Group in 2019.
Now after partnering with Kiwa from EUR 20 to 600 million turnover, Clairfield acted as lead advisor in the sale to SHV, which will support the company in its growth path towards 2 billion in sales.